Lataa...
Update on the management of inflammatory bowel disease: specific role of adalimumab
Anti-tumor necrosis factor alpha (TNF-α) medications are a class of biologics employed in the treatment of patients with inflammatory bowel disease (IBD). Adalimumab is the first fully human monoclonal immunoglobulin directed against TNF-α, which binds with high affinity and specificity to membrane...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3163921/ https://ncbi.nlm.nih.gov/pubmed/21904462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S14558 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|